Cargando…

Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study

BACKGROUND: Oral tauroursodeoxycholic acid (TUDCA) is a commercial drug currently tested in patients with amyotrophic lateral sclerosis (ALS) both singly and combined with sodium phenylbutyrate. This retrospective study aimed to investigate, in a real-world setting, whether TUDCA had an impact on th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zucchi, Elisabetta, Musazzi, Umberto Maria, Fedele, Guido, Martinelli, Ilaria, Gianferrari, Giulia, Simonini, Cecilia, Fini, Nicola, Ghezzi, Andrea, Caputo, Maria, Sette, Elisabetta, Vacchiano, Veria, Zinno, Lucia, Anceschi, Pietro, Canali, Elena, Vinceti, Marco, Ferro, Salvatore, Mandrioli, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570688/ https://www.ncbi.nlm.nih.gov/pubmed/37842553 http://dx.doi.org/10.1016/j.eclinm.2023.102256

Ejemplares similares

CSF Heavy Neurofilament May Discriminate and Predict Motor Neuron Diseases with Upper Motor Neuron Involvement
por: Simonini, Cecilia, et al.
Publicado: (2021)

Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study
por: Gianferrari, Giulia, et al.
Publicado: (2023)

The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis
por: Martinelli, Ilaria, et al.
Publicado: (2022)

A Variant in TBCD Associated with Motoneuronopathy and Corpus Callosum Hypoplasia: A Case Report
por: Caputo, Maria, et al.
Publicado: (2023)

Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype
por: Gianferrari, Giulia, et al.
Publicado: (2023)

Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy
por: Gianferrari, Giulia, et al.
Publicado: (2022)

Young Onset Alzheimer’s Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association
por: Vinceti, Giulia, et al.
Publicado: (2023)

High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial
por: Zucchi, Elisabetta, et al.
Publicado: (2019)

Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder
por: Zucchi, Elisabetta, et al.
Publicado: (2019)

The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum
por: Vinceti, Giulia, et al.
Publicado: (2023)

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
por: Elia, A. E., et al.
Publicado: (2015)

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
por: Mandrioli, Jessica, et al.
Publicado: (2023)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

Frequency of Parkinson’s Disease Genes and Role of PARK2 in Amyotrophic Lateral Sclerosis: An NGS Study
por: Vacchiano, Veria, et al.
Publicado: (2022)

Mitochondrial and Endoplasmic Reticulum Alterations in a Case of Amyotrophic Lateral Sclerosis Caused by TDP-43 A382T Mutation
por: Zanini, Giada, et al.
Publicado: (2022)

Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study
por: Filippini, Tommaso, et al.
Publicado: (2020)

Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study
por: Filippini, Tommaso, et al.
Publicado: (2020)

Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance
por: Fortuna, Andrea, et al.
Publicado: (2022)

Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment
por: Wormser, Uri, et al.
Publicado: (2016)

Correction to: Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance
por: Fortuna, Andrea, et al.
Publicado: (2023)

Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer’s Dementia
por: Urbano, Teresa, et al.
Publicado: (2022)

Reply to Comment on “Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study”
por: Filippini, Tommaso, et al.
Publicado: (2020)

FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis
por: Mandrioli, Jessica, et al.
Publicado: (2019)

Mechanisms of tauroursodeoxycholate-mediated inhibition of apoptosis
por: Sommerfeld, Annika, et al.
Publicado: (2014)

Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis
por: Leone, Maurizio A., et al.
Publicado: (2022)

Co-occurrence of amyotrophic lateral sclerosis and Leber’s hereditary optic neuropathy: is mitochondrial dysfunction a modifier?
por: Amore, Giulia, et al.
Publicado: (2022)

Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
por: Zucchi, Elisabetta, et al.
Publicado: (2020)

Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis
por: Ahn, Tae-Keun, et al.
Publicado: (2020)

Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study
por: Vacchiano, Veria, et al.
Publicado: (2021)

Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis
por: Mastrangelo, Andrea, et al.
Publicado: (2023)

Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)
por: Mandrioli, Jessica, et al.
Publicado: (2018)

Diagnostic and Prognostic Value of Conventional Brain MRI in the Clinical Work-Up of Patients with Amyotrophic Lateral Sclerosis
por: Rizzo, Giovanni, et al.
Publicado: (2020)

Risk of Amyotrophic Lateral Sclerosis and Exposure to Particulate Matter from Vehicular Traffic: A Case-Control Study
por: Filippini, Tommaso, et al.
Publicado: (2021)

Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex
por: Feng, Rui, et al.
Publicado: (2018)

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
por: Khalaf, Kareem, et al.
Publicado: (2022)

Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis
por: Pike, Colleen M., et al.
Publicado: (2022)

Effect of Tauroursodeoxycholic Acid on Inflammation after Ocular Alkali Burn
por: Huang, Yanqiao, et al.
Publicado: (2022)

The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases
por: Vang, Sheila, et al.
Publicado: (2014)

Tauroursodeoxycholic acid: more than just a neuroprotective bile conjugate
por: Romero-Ramírez, Lorenzo, et al.
Publicado: (2017)

Metabolomics and Lipidomics Study Unveils the Impact of Tauroursodeoxycholic Acid on Hyperlipidemic Mice
por: Cui, Na, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_edn70vbga8lsqa7jd9vllk8ne9